Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_assertion type Assertion NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_head.
- NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_assertion wasGeneratedBy ECO_0000203 NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_provenance.
- NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_assertion wasDerivedFrom befree-2016 NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_provenance.
- NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_assertion SIO_000772 23371322 NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_provenance.
- NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_assertion evidence source_evidence_literature NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_provenance.
- NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_assertion description "[Thus, the siRNA-mediated silencing of PI3K p110β resensitizes PTX-resistant ovarian cancer cells, and may be a useful therapeutic strategy for PTX-resistant ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1049025.RA5fdifBlyC2tMo2FNBDAaZftpIPqpiL52uDuPck4gyc8130_provenance.